• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨骼肌作为对抗癌症恶病质的积极参与者。

The Skeletal Muscle as an Active Player Against Cancer Cachexia.

作者信息

Penna Fabio, Ballarò Riccardo, Beltrà Marc, De Lucia Serena, García Castillo Lorena, Costelli Paola

机构信息

Department of Clinical and Biological Sciences, Interuniversity Institute of Myology, University of Turin, Turin, Italy.

出版信息

Front Physiol. 2019 Feb 18;10:41. doi: 10.3389/fphys.2019.00041. eCollection 2019.

DOI:10.3389/fphys.2019.00041
PMID:30833900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6387914/
Abstract

The management of cancer patients is frequently complicated by the occurrence of cachexia. This is a complex syndrome that markedly impacts on quality of life as well as on tolerance and response to anticancer treatments. Loss of body weight, wasting of both adipose tissue and skeletal muscle and reduced survival rates are among the main features of cachexia. Skeletal muscle wasting has been shown to depend, mainly at least, on the induction of protein degradation rates above physiological levels. Such hypercatabolic pattern is driven by overactivation of different intracellular proteolytic systems, among which those dependent on ubiquitin-proteasome and autophagy. Selective rather than bulk degradation of altered proteins and organelles was also proposed to occur. Within the picture described above, the muscle is frequently considered a sort of by-stander tissue where external stimuli, directly or indirectly, can poise protein metabolism toward a catabolic setting. By contrast, several observations suggest that the muscle reacts to the wasting drive imposed by cancer growth by activating different compensatory strategies that include anabolic capacity, the activation of autophagy and myogenesis. Even if muscle response is eventually ill-fated, its occurrence supports the idea that in the presence of appropriate treatments the development of cancer-induced wasting might not be an ineluctable event in tumor hosts.

摘要

癌症患者的管理常常因恶病质的出现而变得复杂。这是一种复杂的综合征,对生活质量以及对抗癌治疗的耐受性和反应都有显著影响。体重减轻、脂肪组织和骨骼肌消瘦以及生存率降低是恶病质的主要特征。骨骼肌消瘦已被证明至少主要取决于蛋白质降解率高于生理水平的诱导。这种高分解代谢模式是由不同细胞内蛋白水解系统的过度激活驱动的,其中那些依赖泛素 - 蛋白酶体和自噬的系统。还提出了对改变的蛋白质和细胞器进行选择性而非大量降解。在上述情况中,肌肉常被视为一种旁观者组织,外部刺激可直接或间接使蛋白质代谢倾向于分解代谢状态。相比之下,一些观察结果表明,肌肉通过激活不同的补偿策略来应对癌症生长所施加的消瘦驱动,这些策略包括合成代谢能力、自噬激活和肌生成。即使肌肉反应最终命运不佳,其出现也支持了这样一种观点,即在存在适当治疗的情况下,癌症诱导的消瘦在肿瘤宿主中可能并非不可避免的事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/a320d20df7f6/fphys-10-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/7b66f984769c/fphys-10-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/e0504fa3edcc/fphys-10-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/a320d20df7f6/fphys-10-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/7b66f984769c/fphys-10-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/e0504fa3edcc/fphys-10-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab5/6387914/a320d20df7f6/fphys-10-00041-g003.jpg

相似文献

1
The Skeletal Muscle as an Active Player Against Cancer Cachexia.骨骼肌作为对抗癌症恶病质的积极参与者。
Front Physiol. 2019 Feb 18;10:41. doi: 10.3389/fphys.2019.00041. eCollection 2019.
2
Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.特异性蛋白酶体抑制剂硼替佐米对癌症相关肌肉消耗的影响。
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):345-54. doi: 10.1002/jcsm.12050. Epub 2015 Jul 7.
3
Interference with Ca-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia.干扰钙依赖性蛋白水解不会改变实验性癌症恶病质中肌肉萎缩的进程。
Front Physiol. 2017 Apr 19;8:213. doi: 10.3389/fphys.2017.00213. eCollection 2017.
4
Mediators of cachexia in cancer patients.癌症患者恶病质的介质。
Nutrition. 2019 Oct;66:11-15. doi: 10.1016/j.nut.2019.03.012. Epub 2019 Mar 29.
5
Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies.癌症恶病质相关骨骼肌丢失的分子机制:临床前和临床研究数据分析。
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1150-1167. doi: 10.1002/jcsm.13073. Epub 2023 Mar 2.
6
The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?氧化还原平衡:对抗癌症恶病质中肌肉消耗的干预靶点?
Antioxid Redox Signal. 2020 Sep 10;33(8):542-558. doi: 10.1089/ars.2020.8041. Epub 2020 Mar 5.
7
Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.对癌症恶病质衰弱状态的思考:骨骼肌减少。
Fundam Clin Pharmacol. 2023 Dec;37(6):1079-1091. doi: 10.1111/fcp.12931. Epub 2023 Jul 20.
8
Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.针对胰腺癌诱导恶病质的分子治疗策略。
World J Gastrointest Surg. 2018 Dec 27;10(9):95-106. doi: 10.4240/wjgs.v10.i9.95.
9
Creatine modulates cellular energy metabolism and protects against cancer cachexia-associated muscle wasting.肌酸可调节细胞能量代谢,并预防癌症恶病质相关的肌肉萎缩。
Front Pharmacol. 2022 Dec 7;13:1086662. doi: 10.3389/fphar.2022.1086662. eCollection 2022.
10
Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.癌症相关性恶病质中骨骼肌蛋白周转的调节
Nutrition. 2000 Oct;16(10):1015-8. doi: 10.1016/s0899-9007(00)00407-x.

引用本文的文献

1
Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects.有氧运动在微小RNA中的分子机制及抗肿瘤作用
Front Oncol. 2025 Aug 13;15:1595982. doi: 10.3389/fonc.2025.1595982. eCollection 2025.
2
A Diet Rich in Essential Amino Acids Inhibits the Growth of HCT116 Human Colon Cancer Cell In Vitro and In Vivo.富含必需氨基酸的饮食在体外和体内均可抑制HCT116人结肠癌细胞的生长。
Int J Mol Sci. 2025 Jul 21;26(14):7014. doi: 10.3390/ijms26147014.
3
Blood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial.

本文引用的文献

1
Muscle protein anabolism in advanced cancer patients: response to protein and amino acids support, and to physical activity.晚期癌症患者的肌肉蛋白合成代谢:对蛋白质和氨基酸支持以及体育活动的反应。
Ann Oncol. 2018 Feb;29 Suppl 2:ii10-ii17. doi: 10.1093/annonc/mdx809. Epub 2019 Dec 4.
2
Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.成人癌症患者恶病质的药物治疗:临床试验的系统评价。
BMC Cancer. 2018 Nov 27;18(1):1174. doi: 10.1186/s12885-018-5080-4.
3
Contraction and nutrition interaction promotes anabolism in cachectic muscle.
围手术期血流限制运动预防胰腺、胆道和肝癌患者肌肉量丢失:PREV-Ex 随机对照试验研究方案。
Trials. 2024 Jun 4;25(1):356. doi: 10.1186/s13063-024-08207-5.
4
Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia.氨基酸与运动对肌肉蛋白质周转的影响,尤其是在癌症恶病质中的影响。
Cancers (Basel). 2024 May 18;16(10):1921. doi: 10.3390/cancers16101921.
5
Hepatocellular carcinoma and musculoskeletal system: A narrative literature review.肝细胞癌与肌肉骨骼系统:一篇叙述性文献综述。
World J Gastroenterol. 2024 Apr 21;30(15):2109-2117. doi: 10.3748/wjg.v30.i15.2109.
6
Exploring skeletal muscle tolerance and whole-body metabolic effects of FDA-approved drugs in a volumetric muscle loss model.探讨容积性肌肉丢失模型中 FDA 批准药物对骨骼肌耐受性和全身代谢的影响。
Physiol Rep. 2023 Jun;11(12):e15756. doi: 10.14814/phy2.15756.
7
The Role of Natural Products in the Improvement of Cancer-Associated Cachexia.天然产物在改善癌症相关性恶病质中的作用。
Int J Mol Sci. 2023 May 15;24(10):8772. doi: 10.3390/ijms24108772.
8
Chemotherapy-Induced Molecular Changes in Skeletal Muscle.化疗诱导的骨骼肌分子变化。
Biomedicines. 2023 Mar 15;11(3):905. doi: 10.3390/biomedicines11030905.
9
The underexplored links between cancer and the internal body climate: Implications for cancer prevention and treatment.癌症与人体内部环境之间尚未充分探索的联系:对癌症预防和治疗的启示。
Front Oncol. 2022 Dec 22;12:1040034. doi: 10.3389/fonc.2022.1040034. eCollection 2022.
10
Amino Acids in Cancer and Cachexia: An Integrated View.癌症与恶病质中的氨基酸:综合观点
Cancers (Basel). 2022 Nov 19;14(22):5691. doi: 10.3390/cancers14225691.
收缩与营养相互作用促进恶病质肌肉的合成代谢。
Curr Opin Clin Nutr Metab Care. 2019 Jan;22(1):60-67. doi: 10.1097/MCO.0000000000000527.
4
Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential.肌肉再生被癌症恶病质破坏,而肌肉干细胞潜能并未丧失。
PLoS One. 2018 Oct 9;13(10):e0205467. doi: 10.1371/journal.pone.0205467. eCollection 2018.
5
PERK regulates skeletal muscle mass and contractile function in adult mice.PERK 调节成年小鼠的骨骼肌质量和收缩功能。
FASEB J. 2019 Feb;33(2):1946-1962. doi: 10.1096/fj.201800683RR. Epub 2018 Sep 11.
6
Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition.保留肌肉量作为一种减轻癌症化疗对身体组成毒性作用的策略。
Curr Opin Support Palliat Care. 2018 Dec;12(4):420-426. doi: 10.1097/SPC.0000000000000382.
7
The role of Pitx2 and Pitx3 in muscle stem cells gives new insights into P38α MAP kinase and redox regulation of muscle regeneration.Pitx2 和 Pitx3 在肌肉干细胞中的作用为 P38α MAP 激酶和肌肉再生的氧化还原调节提供了新的见解。
Elife. 2018 Aug 14;7:e32991. doi: 10.7554/eLife.32991.
8
Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin.棕色脂肪组织通过分泌肌肉生长抑制素来控制骨骼肌功能。
Cell Metab. 2018 Oct 2;28(4):631-643.e3. doi: 10.1016/j.cmet.2018.07.004. Epub 2018 Aug 2.
9
Cachectic Cancer Patients: Immune to Checkpoint Inhibitor Therapy?消瘦型癌症患者:对免疫检查点抑制剂治疗有抵抗力?
Clin Cancer Res. 2018 Dec 1;24(23):5787-5789. doi: 10.1158/1078-0432.CCR-18-1847. Epub 2018 Jul 17.
10
Nutrition support and clinical outcome in advanced cancer patients.晚期癌症患者的营养支持与临床结局。
Proc Nutr Soc. 2018 Nov;77(4):388-393. doi: 10.1017/S0029665118000459. Epub 2018 Jul 13.